- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Organogenesis Hldgs (NASDAQ:ORGO), Quotes and News Summary
Organogenesis Hldgs (NASDAQ: ORGO)
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-08 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.080 | (EXPECTED) 2022-08-09 | |||||
| REV | 120.900M | ||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Organogenesis Hldgs Questions & Answers
You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.
Other companies in Organogenesis Hldgs’s space includes: Cogent Biosciences (NASDAQ:COGT), Immatics (NASDAQ:IMTX), Adicet Bio (NASDAQ:ACET), Sangamo Therapeutics (NASDAQ:SGMO) and Agenus (NASDAQ:AGEN).
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by SVB Leerink on Wednesday, November 10, 2021. The analyst firm set a price target for 20.00 expecting ORGO to rise to within 12 months (a possible 223.10% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $6.19 last updated August 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for Organogenesis Hldgs.
Organogenesis Hldgs’s Q3 earnings are confirmed for Tuesday, November 8, 2022.
There is no upcoming split for Organogenesis Hldgs.
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.